Phase 2 Upper Urinary Tract Urothelial Carcinoma Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery
Upper Urinary Tract Urothelial Carcinoma
Peking University First Hospital60 enrolled1 locationNCT06210490
Recruiting
Phase 2
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
Upper Urinary Tract Urothelial CarcinomaKidney PreservationHER-2 ADC+1 more
RenJi Hospital20 enrolled1 locationNCT05912816
Recruiting
Phase 2
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
Upper Urinary Tract Urothelial CarcinomaRenal InsufficiencySolitary Kidney
Fudan University20 enrolled1 locationNCT06354231